FDA Warning: Hidden Dangers of Smuggled Tirzepatide in Peptide Markets The FDA has issued a warning about the risks of smuggled tirzepatide as the peptide therapeutics market grows rapidly. The market is expected Find out a USA-approved contract manufacturer for Eli, a GMP manufacturer for Retatrutide, and a Cagrillintide USA manufacturer. FDA-app